Sandhoff Disease

Below you will find more information about Sandhoff Disease from Medigest. If you believe that you are suffering from any of the symptoms of Sandhoff Disease it is important that you obtain an accurate diagnosis from a medical professional to ensure that you obtain the correct medication or treatment for your condition. There are medical conditions that carry similar symptoms associated with Sandhoff Disease and therefore the information provided by Medigest is offered as a guideline only and should never be used in preference to seeking professional medical advice. The information relating to Sandhoff Disease comes from a third party source and Medigest will not be held liable for any inaccuracies relating to the information shown.


Sandhoff disease is a genetic autosomal recessive disorder affecting lipid storage, leading to progressive damage in the nerve cells of the brain and spinal cord.


Sandhoff disease can be diagnosed through a biopsy of sample tissues from the liver. Cells and tissues can be molecularly analyzed to screen for a genetic metabolic disorder. An enzyme assay, genetic testing, and occasionally a urinalysis are also common diagnostic steps.


There is currently no specific treatment to cure Sandhoff disease. However, an affected patient needs to maintain proper nutrition, clear airways, and hydration. Anticonvulsants are sometimes advised to control seizures. Appropriate medication is also used to treat respiratory infections.

Symptoms and Signs

The most common and severe type of Sandhoff disease occurs during infancy, particularly at age 3-6 months old, at which time development slows and muscles weaken. As Sandhoff disease progresses, affected infants develop seizures, hearing loss, vision impairment, mental retardation, and paralysis. Cherry-red spot, a type of eye abnormality, is a characteristic sign of Sandhoff disease. In some cases, affected infants show bone abnormalities and/or enlarged organs. Other types of Sandhoff disease are relatively rare. Symptoms may appear in childhood, adolescence or adulthood, but are often milder than those in infantile Sandhoff disease. As in the infantile form, common symptoms include motor weakness, mental deterioration, speech problems, ataxia (loss of muscle coordination) and other related problems.


Sandhoff disease is caused by mutations in the HEXB gene. This gene is primarily responsible for controlling the production of beta-hexosaminidase A and beta-hexosaminidase B, two enzymes that break down fatty substances, complex sugars, and other molecules that are linked to sugars. HEXB gene mutations disturb the normal functioning of these enzymes, leading to a toxic level buildup of GM2 ganglioside (fatty compound broken down by beta-hexosaminidase A) and other compounds inside cells.

Discuss Sandhoff Disease in our forums

Discuss Sandhoff Disease with other members of Medigest in our forums.